NIA Announces its #1 California CBD Stock Suggestion!

AHG has only 67,752,095 shares outstanding, for a current market cap at $0.37 per share of only CAD$25.07 million or USD$18.6 million. At AHG's current price of $0.37 per share this is undoubtedly the biggest opportunity that NIA has ever uncovered in the cannabis industry. The stock is undiscovered by cannabis investors - MAJOR developments have taken place in recent weeks but gone completely unnoticed by investors. We expect AHG to soon become the #1 cannabis play in the market!

Worldwide Google searches for "CBD" have reached new all-time highs for the last 21 consecutive months - exploding by 212.5% since August 2017! AHG will soon become a major player in the CBD space after announcing an agreement to acquire Blaine Labs Inc., a leading manufacturer and distributor of FDA-approved and cGMP-certified dermatological products, with over 50 SKUs currently available in major retailers, including Walmart, Amazon, CVS and Walgreens. AHG intends to transform Blaine Labs into an international CBD leader, starting with expansion throughout AHG's own extensive physician networks!

In June 2018, NIA predicted that CBD-infused beverage stocks would become the #1 hottest plays in the market and said that it believed Koios Beverage (CSE: KBEV) would become the best performing CBD-infused beverage stock. In September 2018, following rumors of Coca-Cola looking to enter the CBD-infused beverage space, NIA's #1 CBD-infused beverage stock suggestion KBEV exploded by 425% from a low of $0.20 per share to a high of $1.05 per share. During KBEV's September 2018 rally from $0.20 up to $1.05 it was the #1 largest percentage gainer in the entire market!

Two months ago, NIA predicted that California focused cannabis stocks would become the new #1 hottest plays in the market, and said that it believed Transcanna (CSE: TCAN) would become the best performing California cannabis stock. Over the following seven weeks, TCAN exploded by 159.67% from NIA's suggestion price of $3 per share to a high of $7.79 per share. This made TCAN the #1 largest gaining California cannabis stock and #2 largest gaining overall cannabis stock in the market!

AHG is an established, well-diversified California focused cannabis company that we believe is perfectly positioned to become the next major player in the CBD-infused products space. So far, AHG has remained under the radar of most cannabis investors, with the company doing very little to market its stock to the cannabis investment community, but we expect word to spread about AHG very quickly in the weeks ahead!

Blaine Labs has 23 years of operating history in Southern California and AHG will be building on its leading portfolio of medical grade products including treatments for psoriasis, scar-tissue, fungus and pain management - by creating new CBD-infused versions of these products! Last year, Blaine Labs generated in excess of US$14 million in revenue with net income of approximately US$8 million and it has no debt!

AHG is targeting a massive rollout of a new proprietary line of CBD-infused products through both the existing Blaine Labs distribution contacts and AHG's own extensive database of physicians, clinics and patients already using AHG's cannabis software products!

If you go to the web site of Blaine Labs, you will see how excited the company is about entering the CBD-infused products space with AHG. The latest two articles posted to the company's home page were written by Blaine Labs founder Dr. Robert Blaine about CBD! On March 1, 2019, Dr. Robert Blaine posted an article he wrote entitled, 'The Endocannabinoid System and Podiatry' - click here to read this article. This is probably the best written article that we have ever read that explains the differences between CBD, THC, and Hemp. It explains how Blaine Labs could potentially help solve the opioid epidemic. According to Dr. Blaine, "We can help manage pain with CBD applied topically and taken systemically (oral or sublingual) without the side effects of opiates."

On April 1, 2019, Dr. Robert Blaine posted another CBD article, 'Common Myths Debunked About CBD' - click here to read this article. In this article, Dr. Blaine answers: Will CBD make me high and can I overdose? Will CBD show up on a drug test? Does CBD come from marijuana? Is CBD a cure all? Is CBD legal? Will CBD make me sleepy?

The products of Blaine Labs are extremely popular on Amazon and sell under a variety of very strong brands including RevitaDerm. One RevitaDerm product is their Keratolytic Emollient: a complete callus-care solution, formulated to remove thick, callused areas while rehydrating skin to a healthy appearance. It has 401 reviews with an average rating of 4.5 stars (75% of reviewers gave it a perfect 5 stars!)! Click here to see for yourself!

Another popular RevitaDERM product is their Psoriasis Treatment: formulated specifically to address the many symptoms of Psoriasis and Eczema including itchy, flaking, dry, and cracked skin. It has 75 reviews with an average rating of 4 stars (55% of reviewers gave it a perfect 5 stars)! Click here to see for yourself! CVS also sells it on their web site with an average rating of 5 stars: click here to see its CVS listing!

Also extremely popular on Amazon is Dr. Blaine's Tineacide Antifungal Cream: clinically proven to treat and kill the skin fungus that causes nail and foot fungus. Tineacide is the most doctor recommended, non-prescription antifungal cream! It has 287 reviews with an average rating of 3.7 stars (52% of reviewers gave it a perfect 5 stars)! Click here to see for yourself! CVS also sells it on their web site with an average rating of 4.4 stars: click here to see its CVS listing!

One of the most well-known Blaine Labs products is its VITÉ20 Antifungal Cream, one of the first products developed by Dr. Blaine after his father tragically passed away due to complications from fungal toenails. He had a goal of developing the most effective antifungal cream on the market and judging by the 110 reviews with an average rating of 4.4 stars (68% of reviewers gave it a perfect 5 stars), he has achieved his goal - especially considering that it has received Amazon's Choice Award! Click here to see for yourself!

VITÉ20 was so successful that Blaine Labs decided to create an entire lineup of products under that brand - with Amazon selling all of them! Click here to see Amazon's entire lineup of VITÉ20 products for sale! To further grow sales of its VITÉ20 line of products, Blaine Labs recently launched its own e-commerce site dedicated to the VITÉ20 brand: www.vite20.com.

Amazon also sells the Blaine Labs PerformanceFoot Verucide Wart Remover, which contains the same active ingredient as competing wart remover products: Salicylic Acid. However, Blaine Labs has created a superior wart remover that achieves much more effective results, because it also contains Papaya Extract - a natural surfactant used to bring the Salicylic Acid deep into the affected skin. It has 11 reviews with an average rating of 4.1 stars (64% of reviewers gave it a perfect 5 stars)! Click here to see for yourself!

The Blaine Labs product that NIA believes will become the top seller for AHG in the future is their Ortho-Nesic Pain-Relieving Gel, once AHG launches a CBD-infused version of the product! Already, the non-CBD product gets recommended on a daily basis by many medical professionals around the world, for pre- and post-exercise application to reduce swelling and stiffness. Even without CBD, many customers on Amazon are calling it the most effective over-the-counter pain-relieving gel on the market, with an unbelievable 76% of reviewers giving it a perfect 5 stars! Click here to see for yourself!

We can't imagine what sales will explode to once AHG releases a CBD-infused version of the Blaine Labs Ortho-Nesic Pain-Relieving Gel! In recent months, Dr. Blaine has been giving samples of it to his patients (infused with 25mg of CBD) for them to try on their area of pain. As described by Dr. Blaine, "I hand the patient a tube and leave the treatment room about ten minutes while seeing other patients. EVERY single patient, without exception, experienced IMMEDIATE pain relief!"

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA is receiving compensation from AHG of USD$40,000 cash for a one-month marketing contract. Never make investment decisions based on anything NIA says. This message is meant for informational and educational purposes only and does not provide investment advice.